| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6db1542efe4f0101ccad244019d1a0bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5d41536044bdc6cbf0b45da0b0ba9e34 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
| filingDate |
2006-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b40b3a7f105f00420d13e8fd15af0a0f |
| publicationDate |
2008-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20080086436-A |
| titleOfInvention |
Camptothecin derivatives as chemoradiosensitizers |
| abstract |
Camptothecin-based compounds are useful for the treatment of neoplasia in mammalian subjects when administered to a subject in combination with radiotherapy, i.e., a radioactive material from a subject's external source or a therapy treating the tumor. By placing one or more electron-affinity groups around the camptothecin structure, the camptothecin-based compounds can be modified to enhance their value in combination with radiotherapy. Novel camptothecin-based compounds are disclosed that are useful in the treatment of cancer by administration of the novel compounds alone or in combination with radiotherapy. |
| priorityDate |
2005-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |